The effect of a periodontal intervention on cardiovascular risk markers in Indigenous Australians with periodontal disease: the PerioCardio study

January 2011
BMC Public Health;2011, Vol. 11 Issue 1, p729
Academic Journal
The article presents a PerioCardio study conducted on examining the effect of a periodontal intervention on cardiovascular risk markers in Indigenous Australians with periodontal disease. It determines the effects of periodontal treatment on changes in measures of vascular health and inflammation. It highlights the methods employed in conducting the study. It reports that the effectiveness of an intervention is aimed at improving periodontal and cardiovascular health.


Related Articles

  • Relationship between components of the metabolic syndrome and job strain using a brief job stress questionnaire (BJSQ). Kawada, Tomoyuki // International Archives of Occupational & Environmental Health;Aug2013, Vol. 86 Issue 6, p725 

    A letter to the editor is presented in response to the article "The role of psychosocial stress at work for the development of cardiovascular diseases: a systematic review," by E. M. Backe and colleagues in the 2012 issue.

  • Dietary fat intake and prevention of cardiovascular disease. Hooper, Lee; Summerbell, Carolyn D.; Higgins, Julian P. T.; Thompson, Rachel L.; Capps, Nigel E.; Smith, George Davey; Riemersma, Rudolph A.; Ebrahim, Shah // BMJ: British Medical Journal (International Edition);03/31/2001, Vol. 322 Issue 7289, p757 

    Assesses the effect of reduction or modification of dietary fat intake on total and cardiovascular mortality and cardiovascular morbidity. Methods; Results; Conclusion that there is a small but potentially important reduction in cardiovascular risk with reduction or modification of dietary fat...

  • The relation of metabolic syndrome according to five definitions to cardiovascular risk factors - a population-based study. Cheng-Chieh Lin; Chiu-Shong Liu; Chia-Ing Li; Wen-Yuan Lin; Ming-May Lai; Tsann Lin; Pei-Chia Chang; Yih-Dar Lee; Ching-Chu Chen; Chih-Hsueh Lin; Chuan-Wei Yang; Chih-Yi Hsiao; Chen, Walter; Tsai-Chung Li // BMC Public Health;2009, Vol. 9, p484 

    Background: Although National Cholesterol Education Program (NCEP), International Diabetes Federation (IDF), American Heart Association and National Heart, Lung and Blood Institute (AHA/NHLBI), World Health Organization (WHO), and the European Group for the Study of Insulin Resistance (EGIR)...

  • Rationale and methods of the cardiometabolic valencian study (escarval-risk) for validation of risk scales in mediterranean patients with hypertension, diabetes or dyslipidemia. Gil-Guillen, Vicente; Orozco-Beltran, Domingo; Redon, Josep; Pita-Fernandez, Salvador; Navarro-Pérez, Jorge; Pallares, Vicente; Valls, Francisco; Fluixa, Carlos; Fernandez, Antonio; Martin-Moreno, Jose M; Pascual-de-la-Torre, Manuel; Trillo, Jose L.; Durazo-Arvizu, Ramon; Cooper, Richard; Hermenegildo, Marta; Rosado, Luis // BMC Public Health;2010, Vol. 10, p717 

    Background: The Escarval-Risk study aims to validate cardiovascular risk scales in patients with hypertension, diabetes or dyslipidemia living in the Valencia Community, a European Mediterranean region, based on data from an electronic health recording system comparing predicted events with...

  • Do prescription stimulants increase the risk of adverse cardiovascular events?: A systematic review.  // BMC Cardiovascular Disorders;2012, Vol. 12 Issue 1, p41 

    The article presents the findings of a systematic review conducted on examining whether prescription stimulants increase the risk of adverse cardiovascular events. It discusses the methodology of the research. It reveals that the association between prescription stimulant use and adverse...

  • Urinary Sodium and Cardiovascular Disease Risk: Informing Guidelines for Sodium Consumption. Whelton, Paul K. // JAMA: Journal of the American Medical Association;11/23/2011, Vol. 306 Issue 20, p2262 

    The article offers insights on a study which examined the association between sodium intake and cardiovascular disease (CVD) risk published in this issue. It notes that the study was able to confirm a J-shaped relationship between sodium excretion and CVD risk. It questions the validity of the...

  • CVD Risk Assessing 90% of a country: the New Zealand experience. Arcus, K.; Devlin, G. // Heart, Lung & Circulation;2015 Supplement 3, Vol. 24, pS453 

    No abstract available.

  • Individualizing Targets and Tactics for High-Risk Patients With Type 2 Diabetes. Riddle, Matthew C.; Karl, Diane M. // Diabetes Care;Oct2012, Vol. 35 Issue 10, p2100 

    This article summarizes the original findings of studies on cardiovascular risk in type 2 diabetes mellitus. These include the Action to Control Cardiovascular Risk in Diabetes (ACCORD), the Action in Diabetes and Vascular Disease: Preterax and Diamacron MR Controlled Evaluation (ADVANCE) and...

  • Periodontal treatment for cardiovascular risk factors: a systematic review. Deng Linkai; Li Chunjie; Li Qian; Zhang Yukui; Zhao Hongwei // West China Journal of Stomatology;oct2013, Vol. 31 Issue 5, p463 

    Objective To evaluate the efficacy of periodontal treatment for the management of cardiovascular risk factors. Methods Eligible studies in Cochrane Controlled Trials Register/CENTRAL, PubMed, EMBASE, and China Biology Medicine disc (CBMdisc) were searched until October 13, 2011. References of...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics